221 reports of this reaction
3.5% of all COLESTIPOL HYDROCHLORIDE reports
#3 most reported adverse reaction
NAUSEA is the #3 most commonly reported adverse reaction for COLESTIPOL HYDROCHLORIDE, manufactured by Pharmacia & Upjohn Company LLC. There are 221 FDA adverse event reports linking COLESTIPOL HYDROCHLORIDE to NAUSEA. This represents approximately 3.5% of all 6,329 adverse event reports for this drug.
Patients taking COLESTIPOL HYDROCHLORIDE who experience nausea should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
NAUSEA is moderately reported among COLESTIPOL HYDROCHLORIDE users, representing a notable but not dominant share of adverse events.
In addition to nausea, the following adverse reactions have been reported for COLESTIPOL HYDROCHLORIDE:
The following drugs have also been linked to nausea in FDA adverse event reports:
NAUSEA has been reported as an adverse event in 221 FDA reports for COLESTIPOL HYDROCHLORIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.
NAUSEA accounts for approximately 3.5% of all adverse event reports for COLESTIPOL HYDROCHLORIDE, making it one of the most commonly reported side effect.
If you experience nausea while taking COLESTIPOL HYDROCHLORIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.